πŸ‡ΊπŸ‡Έ FDA
Patent

US 7414046

Gyrase inhibitors and uses thereof

granted A61KA61K31/00A61K31/4184

Quick answer

US patent 7414046 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/00, A61K31/4184, A61K31/423, A61K31/437